Global Cannabidiol (CBD) Market (2019 Edition): Analysis By Source (Hemp, Marijuana), Application (Pharmaceuticals, Cosmetics Industry, Others): Opportunities and Forecast (2017-2024)
EXECUTIVE SUMMARY
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cannabidiol market. The report analyses the global cannabidiol Market by source (hemp, marijuana) and by application (Pharmaceuticals, cosmetics, others) for the Regions (North America, Europe, APAC, ROW) and By Country (U.S, Canada, Germany, Australia) for the historical period of 2017-2018 and the forecast period of 2019-2024.
According to the Azoth Analytics research, the global cannabidiol market was valued at USD 708.55 for the year 2018.
Over the recent years, cannabidiol market has been witnessing considerable growth on the back of rise in demand of cannabidiol, rapid legalization across countries globally, growing acceptance and awareness among consumers regarding therapeutic effect of cannabidiol etc.
In addition, increasing investment, escalating number of cannabidiol manufactures, introduction of CBD infused cosmetic product etc. is anticipated to provide higher momentum to the market growth in the forecast period. However, strict regulation regarding the legalization of cannabidiol and illegal market of cannabidiol has been hindering the market growth.
SCOPE OF THE REPORT
Global Cannabidiol Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cannabidiol market. The report analyses the global cannabidiol Market by source (hemp, marijuana) and by application (Pharmaceuticals, cosmetics, others) for the Regions (North America, Europe, APAC, ROW) and By Country (U.S, Canada, Germany, Australia) for the historical period of 2017-2018 and the forecast period of 2019-2024.
According to the Azoth Analytics research, the global cannabidiol market was valued at USD 708.55 for the year 2018.
Over the recent years, cannabidiol market has been witnessing considerable growth on the back of rise in demand of cannabidiol, rapid legalization across countries globally, growing acceptance and awareness among consumers regarding therapeutic effect of cannabidiol etc.
In addition, increasing investment, escalating number of cannabidiol manufactures, introduction of CBD infused cosmetic product etc. is anticipated to provide higher momentum to the market growth in the forecast period. However, strict regulation regarding the legalization of cannabidiol and illegal market of cannabidiol has been hindering the market growth.
SCOPE OF THE REPORT
Global Cannabidiol Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)
- Cannabidiol Market– Size, Growth, Forecast
- Analysis By Source: Hemp and Marijuana
- Analysis By Application: Pharmaceuticals, Cosmetic, Others
- Cannabidiol Market– Size, Growth, Forecast
- Analysis By Source: Hemp and Marijuana
- Analysis By Application: Pharmaceuticals, Cosmetic, Others
- Cannabidiol Market– Size, Growth, Forecast
- Analysis By Source: Hemp and Marijuana
- Analysis By Application: Pharmaceuticals, Cosmetic, Others
- Market Dynamics – Drivers and Restraints.
- Market Trends
- Porter Five Forces Analysis.
- SWOT Analysis.
- Company Analysis – Mary’s Medicinals, Medical Marijuana Inc., Canopy growth corporation, Aphria Inc., Folium biosciences.
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1.RESEARCH METHODOLOGY
2.EXECUTIVE SUMMARY
3.STRATEGIC RECOMMENDATIONS
4. CANNABIDIOL (CBD): PRODUCT OUTLOOK
5. GLOBAL CANNABIDIOL MARKET OUTLOOK
6. GLOBAL CANNABIDIOL MARKET DYNAMICS
6.1 Global Cannabidiol Market Drivers
6.1.1 Growing awareness and acceptance of cannabidiol among consumers.
6.1.2 Escalating number of cannabidiol Manufacturers
6.1.3 Improving disposable income and introduction of new products.
6.1.4 Enormous health benefits and potency of cannabidiol.
6.2 Global cannabidiol Market Restraints
6.2.1 Strict regulations against usage of cannabidiol .
6.2.2 Escalating recreational use of cannabidiol .
6.3 Global cannabidiol Market Trends
6.3.1 Government legalizing the production and consumption of Cannabis
6.3.2 Emerging cannabidiol infused food and beverage products
7.PORTER’S FIVE FORCE ANALYSIS: GLOBAL CANNABIDIOL MARKET
8.SWOT ANALYSIS: GLOBAL CANNABIDIOL MARKET
9.GLOBAL CANNABIDIOL MARKET: AN ANALYSIS
10.GLOBAL CANNABIDIOL MARKET – SEGMENT ANALYSIS
10.1 By Source (2018,2024)
10.1.1 Global cannabidiol Market, By Source (hemp): 2017-2024 (USD Million)
10.1.2Global cannabidiol Market, By Source (marijuana): 2017-2024 (USD Million)
10.2 By Application (2018,2024)
10.2.1 Global cannabidiol Market, By Pharmaceuticals: 2017-2024 (USD Million)
10.2.2 Global cannabidiol Market, By Cosmetic : 2017-2024 (USD Million)
10.2.3 Global cannabidiol Market, By Others : 2017-2024 (USD Million)
11. GLOBAL CANNABIDIOL MARKET: REGIONAL ANALYSIS
11.1 Global cannabidiol Market, By Regional Share, By Value (2018,2024)
12. NORTH AMERICA CANNABIDIOL MARKET: AN ANALYSIS
12.1 North America cannabidiol Market, By Value 2017-2024
13. NORTH AMERICA CANNABIDIOL MARKET: SEGMENTAL ANALYSIS
13.1. North America medical cannabis Market, By Source , By Value 2017-2024 (USD Million)
13.2 North America medical cannabis Market, By Application , By Value 2017-2024 (USD Million)
14. UNITED STATES CANNABIDIOL MARKET: COUNTRY ANALYSIS
14.1 United States Cannabidiol Market, By Value
14.2 United States cannabidiol Market, By Source 2017-2024
14.3 United States cannabidiol Market, By Application 2017-2024
15. CANADA CANNABIDIOL (CBD) MARKET: COUNTRY ANALYSIS
15.1 Canada Cannabidiol Market, By Value
15.2 Canada Cannabidiol Market- By Source
15.3 Canada Cannabidiol Market- By Application
16.EUROPE CANNABIDIOL MARKET: AN ANALYSIS
16.1 Europe Cannabidiol Market, By Value 2017-2024
17. EUROPE CANNABIDIOL MARKET: SEGMENT ANALYSIS
17.1 Europe cannabidiol Market, By Source 2017-2024 (USD Million)
17.2 Europe cannabidiol Market, By Application 2017-2024 (USD Million)
18. GERMANY CANNABIDIOL (CBD) MARKET: COUNTRY ANALYSIS
18.1 Germany cannabidiol Market, By Value 2017-2024
18.2 Germany cannabidiol Market, By Source 2017-2024
18.3 Germany cannabidiol Market, By Application 2017-2024
19. ASIA-PACIFIC CANNABIDIOL MARKET: AN ANALYSIS
19.1 Asia-Pacific cannabidiol Market, By Value 2017-2024
20. ASIA PACIFIC CANNABIDIOL MARKET: SEGMENT ANALYSIS
20.1 Asia-Pacific cannabidiol Market, By Source 2017-2024 (USD Million)
20.2 Asia-Pacific cannabidiol Market, By Application 2017-2024 (USD Million)
21. AUSTRALIA CANNABIDIOL (CBD) MARKET: COUNTRY ANALYSIS
21.1 Australia Cannabidiol Market: By Value
21.2 Australia Cannabidiol Market: By Source
21.3 Australia Cannabidiol Market: By Application
22. REST OF THE WORLD CANNABIDIOL MARKET: AN ANALYSIS 2017-2024
22.1 Rest of the World Cannabidiol Market, By Value 2017-2024 (USD Million)
22.2 Rest of the World Cannabidiol Market, By Source 2017-2024 (USD Million)
22.3 Rest of the World Cannabidiol Market, By Application, 2017-2024 (USD Million)
23.COMPANY PROFILES
23.1 Mary’s Medicinals
23.2 Medical Marijuana, INC.
23.3 Canopy Growth Corporation
23.4 Aphria Inc.
23.5 Folium Biosciences
2.EXECUTIVE SUMMARY
3.STRATEGIC RECOMMENDATIONS
4. CANNABIDIOL (CBD): PRODUCT OUTLOOK
5. GLOBAL CANNABIDIOL MARKET OUTLOOK
6. GLOBAL CANNABIDIOL MARKET DYNAMICS
6.1 Global Cannabidiol Market Drivers
6.1.1 Growing awareness and acceptance of cannabidiol among consumers.
6.1.2 Escalating number of cannabidiol Manufacturers
6.1.3 Improving disposable income and introduction of new products.
6.1.4 Enormous health benefits and potency of cannabidiol.
6.2 Global cannabidiol Market Restraints
6.2.1 Strict regulations against usage of cannabidiol .
6.2.2 Escalating recreational use of cannabidiol .
6.3 Global cannabidiol Market Trends
6.3.1 Government legalizing the production and consumption of Cannabis
6.3.2 Emerging cannabidiol infused food and beverage products
7.PORTER’S FIVE FORCE ANALYSIS: GLOBAL CANNABIDIOL MARKET
8.SWOT ANALYSIS: GLOBAL CANNABIDIOL MARKET
9.GLOBAL CANNABIDIOL MARKET: AN ANALYSIS
10.GLOBAL CANNABIDIOL MARKET – SEGMENT ANALYSIS
10.1 By Source (2018,2024)
10.1.1 Global cannabidiol Market, By Source (hemp): 2017-2024 (USD Million)
10.1.2Global cannabidiol Market, By Source (marijuana): 2017-2024 (USD Million)
10.2 By Application (2018,2024)
10.2.1 Global cannabidiol Market, By Pharmaceuticals: 2017-2024 (USD Million)
10.2.2 Global cannabidiol Market, By Cosmetic : 2017-2024 (USD Million)
10.2.3 Global cannabidiol Market, By Others : 2017-2024 (USD Million)
11. GLOBAL CANNABIDIOL MARKET: REGIONAL ANALYSIS
11.1 Global cannabidiol Market, By Regional Share, By Value (2018,2024)
12. NORTH AMERICA CANNABIDIOL MARKET: AN ANALYSIS
12.1 North America cannabidiol Market, By Value 2017-2024
13. NORTH AMERICA CANNABIDIOL MARKET: SEGMENTAL ANALYSIS
13.1. North America medical cannabis Market, By Source , By Value 2017-2024 (USD Million)
13.2 North America medical cannabis Market, By Application , By Value 2017-2024 (USD Million)
14. UNITED STATES CANNABIDIOL MARKET: COUNTRY ANALYSIS
14.1 United States Cannabidiol Market, By Value
14.2 United States cannabidiol Market, By Source 2017-2024
14.3 United States cannabidiol Market, By Application 2017-2024
15. CANADA CANNABIDIOL (CBD) MARKET: COUNTRY ANALYSIS
15.1 Canada Cannabidiol Market, By Value
15.2 Canada Cannabidiol Market- By Source
15.3 Canada Cannabidiol Market- By Application
16.EUROPE CANNABIDIOL MARKET: AN ANALYSIS
16.1 Europe Cannabidiol Market, By Value 2017-2024
17. EUROPE CANNABIDIOL MARKET: SEGMENT ANALYSIS
17.1 Europe cannabidiol Market, By Source 2017-2024 (USD Million)
17.2 Europe cannabidiol Market, By Application 2017-2024 (USD Million)
18. GERMANY CANNABIDIOL (CBD) MARKET: COUNTRY ANALYSIS
18.1 Germany cannabidiol Market, By Value 2017-2024
18.2 Germany cannabidiol Market, By Source 2017-2024
18.3 Germany cannabidiol Market, By Application 2017-2024
19. ASIA-PACIFIC CANNABIDIOL MARKET: AN ANALYSIS
19.1 Asia-Pacific cannabidiol Market, By Value 2017-2024
20. ASIA PACIFIC CANNABIDIOL MARKET: SEGMENT ANALYSIS
20.1 Asia-Pacific cannabidiol Market, By Source 2017-2024 (USD Million)
20.2 Asia-Pacific cannabidiol Market, By Application 2017-2024 (USD Million)
21. AUSTRALIA CANNABIDIOL (CBD) MARKET: COUNTRY ANALYSIS
21.1 Australia Cannabidiol Market: By Value
21.2 Australia Cannabidiol Market: By Source
21.3 Australia Cannabidiol Market: By Application
22. REST OF THE WORLD CANNABIDIOL MARKET: AN ANALYSIS 2017-2024
22.1 Rest of the World Cannabidiol Market, By Value 2017-2024 (USD Million)
22.2 Rest of the World Cannabidiol Market, By Source 2017-2024 (USD Million)
22.3 Rest of the World Cannabidiol Market, By Application, 2017-2024 (USD Million)
23.COMPANY PROFILES
23.1 Mary’s Medicinals
23.2 Medical Marijuana, INC.
23.3 Canopy Growth Corporation
23.4 Aphria Inc.
23.5 Folium Biosciences
LIST OF FIGURES
Figure 1: Global Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 2: Global Cases of Depressive Disorders, By Region, 2019 (In %)
Figure 3: Global Prevalence of Prostate Cancer, 2013-2017, (In Thousands)
Figure 4: Global Health Expenditure Per Capita, By Select Countries, 2017, (USD)
Figure 5: Global Prevalence of Different Types of Cancer, 2014-2018 (In Thousand)
Figure 6: Global Prevalence of Different Types of Cancer, 2014-2018 (In Thousand)
Figure 7: Global Prevalence of Prostate Cancer, 2013-2017, (In Thousands)
Figure 8: Global cannabidiol Market Size, By Source (Hemp), By Value, 2017-2024 (USD Million)
Figure 9: Global cannabidiol Market Size, By Source (Marijuana), By Value, 2017-2024 (USD Million)
Figure 10: Global cannabidiol Market Size, By Source (Pharmaceuticals Industry), By Value, 2017-2024 (USD Million)
Figure 11: Global cannabidiol Market Size, By Application (Cosmetics ), By Value, 2017-2024 (USD Million)
Figure 12: Global cannabidiol Market Size, By Source (Others ), By Value, 2017-2024 (USD Million)
Figure 13: North America Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 14: North America Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 15: North America Population aged 65 and above, 2013-2017 (% of Total)
Figure 16: North America Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 17: North America Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 18: North America Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 19: United States Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 20 US Medical Doctors Per 10000 Population, 2013-2016
Figure 21: US Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 22: US Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 23: USA Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 24: USA Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 25: Canada Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 26: Canada Medical Doctors Per 10000 Population, 2013-2017
Figure 27: Canada Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 28: Canada Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 29: Canada cannabidiol market : By Source (USD Million), 2017-2024
Figure 30: Canada cannabidiol Market- By Application (USD Million), 2017-2024
Figure 31: Europe Cannabidiol Market Size, By Source 2017-2024 (USD Million)
Figure 32: Europe Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 33: Europe Population aged 65 and above, 2013-2017 (% of Total)
Figure 34: Europe Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 35: Europe Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 36: Europe Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 37: Germany Cannabidiol Market Size, By Source , 2017-2024 (USD Million)
Figure 38: Germany Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 39: Germany Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 40: Asia-Pacific Cannabidiol Market Size, By Payments, By Value, 2017-2024 (USD Million)
Figure 41: Asia – Pacific Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 42: Asia- Pacific Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 43: Australia Cannabidiol Market Size, By Value, 2017-2024 (In USD Million)
Figure 44: Australia Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 45: Australia Medical Doctors Per 10000 Population, 2013-2016
Figure 46: Australia Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 47: Australia Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 48: Australia Cannabidiol Market- By Source (USD Millions), 2017-2024
Figure 49: Australia Cannabidiol Market- By Application (USD Millions), 2017-2024
Figure 50: Rest of the World Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 51: Rest of the World Prevalence of Different Types of Neurological Disorders, 2016, 2017, (In Thousands)
Figure 52: Rest of the World Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 53: Rest of the World Population aged 65 and above, 2013-2017 (% of Total)
Figure 54: Rest of the World Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 55: Rest of the World Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 56: Rest of the World Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 57: Medical Marijuana Inc.'s Total Income (2016, 2017 , 2018) (In USD Million)
Figure 58: Medical Marijuana Inc.'s Gross Profit, (2016, 2017, 2018) (In USD Million)
Figure 59: Canopy Growth Corp’s Revenue, 2015-2018 (USD Million)
Figure 60: Aphria Inc. Revenue, 2015-2018 (In USD Million)
Figure 61: Aphria Inc. Gross Profit, 2017, 2018 (In USD Million)
Figure 62: Aphria Inc. Net Income, 2017, 2018 (In USD Million)
Figure 1: Global Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 2: Global Cases of Depressive Disorders, By Region, 2019 (In %)
Figure 3: Global Prevalence of Prostate Cancer, 2013-2017, (In Thousands)
Figure 4: Global Health Expenditure Per Capita, By Select Countries, 2017, (USD)
Figure 5: Global Prevalence of Different Types of Cancer, 2014-2018 (In Thousand)
Figure 6: Global Prevalence of Different Types of Cancer, 2014-2018 (In Thousand)
Figure 7: Global Prevalence of Prostate Cancer, 2013-2017, (In Thousands)
Figure 8: Global cannabidiol Market Size, By Source (Hemp), By Value, 2017-2024 (USD Million)
Figure 9: Global cannabidiol Market Size, By Source (Marijuana), By Value, 2017-2024 (USD Million)
Figure 10: Global cannabidiol Market Size, By Source (Pharmaceuticals Industry), By Value, 2017-2024 (USD Million)
Figure 11: Global cannabidiol Market Size, By Application (Cosmetics ), By Value, 2017-2024 (USD Million)
Figure 12: Global cannabidiol Market Size, By Source (Others ), By Value, 2017-2024 (USD Million)
Figure 13: North America Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 14: North America Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 15: North America Population aged 65 and above, 2013-2017 (% of Total)
Figure 16: North America Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 17: North America Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 18: North America Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 19: United States Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 20 US Medical Doctors Per 10000 Population, 2013-2016
Figure 21: US Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 22: US Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 23: USA Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 24: USA Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 25: Canada Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 26: Canada Medical Doctors Per 10000 Population, 2013-2017
Figure 27: Canada Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 28: Canada Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 29: Canada cannabidiol market : By Source (USD Million), 2017-2024
Figure 30: Canada cannabidiol Market- By Application (USD Million), 2017-2024
Figure 31: Europe Cannabidiol Market Size, By Source 2017-2024 (USD Million)
Figure 32: Europe Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 33: Europe Population aged 65 and above, 2013-2017 (% of Total)
Figure 34: Europe Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 35: Europe Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 36: Europe Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 37: Germany Cannabidiol Market Size, By Source , 2017-2024 (USD Million)
Figure 38: Germany Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 39: Germany Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 40: Asia-Pacific Cannabidiol Market Size, By Payments, By Value, 2017-2024 (USD Million)
Figure 41: Asia – Pacific Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 42: Asia- Pacific Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 43: Australia Cannabidiol Market Size, By Value, 2017-2024 (In USD Million)
Figure 44: Australia Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 45: Australia Medical Doctors Per 10000 Population, 2013-2016
Figure 46: Australia Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 47: Australia Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 48: Australia Cannabidiol Market- By Source (USD Millions), 2017-2024
Figure 49: Australia Cannabidiol Market- By Application (USD Millions), 2017-2024
Figure 50: Rest of the World Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
Figure 51: Rest of the World Prevalence of Different Types of Neurological Disorders, 2016, 2017, (In Thousands)
Figure 52: Rest of the World Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 53: Rest of the World Population aged 65 and above, 2013-2017 (% of Total)
Figure 54: Rest of the World Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 55: Rest of the World Cannabidiol Market- By Source (USD Million), 2017-2024
Figure 56: Rest of the World Cannabidiol Market- By Application (USD Million), 2017-2024
Figure 57: Medical Marijuana Inc.'s Total Income (2016, 2017 , 2018) (In USD Million)
Figure 58: Medical Marijuana Inc.'s Gross Profit, (2016, 2017, 2018) (In USD Million)
Figure 59: Canopy Growth Corp’s Revenue, 2015-2018 (USD Million)
Figure 60: Aphria Inc. Revenue, 2015-2018 (In USD Million)
Figure 61: Aphria Inc. Gross Profit, 2017, 2018 (In USD Million)
Figure 62: Aphria Inc. Net Income, 2017, 2018 (In USD Million)
